Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-01-04 @ 1:15 PM
Study NCT ID:
NCT05387603
Status:
RECRUITING
Last Update Posted:
2025-09-10
First Post:
2022-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
Sponsor:
Lund University Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuroendocrine Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Neuroendocrine tumors | View |
| None | Radionuclide therapy | View |
| None | Personalized radionuclide therapy | View |
| None | 177Lu-DOTATOC | View |
| None | Capecitabine | View |
| None | Dosimetry-based radionuclide therapy | View |
| None | Somatostatin receptor | View |
| None | Lutetium | View |
| None | Beta- and gamma-emitting radionuclide | View |
| None | Translational research | View |